Cytarabine, Daunorubicin, and Gemtuzumab ozogamicin

About

Membership operator: AND

Therapies: 3

Therapies

Cytarabine (tx:ncit:C408)

Daunorubicin (tx:ncit:C62091)

Gemtuzumab ozogamicin (tx:ncit:C1806)

Therapeutic response

Precision oncology relationships for therapeutic response involving this therapy group.

Organizations
Biomarkers
Cancer types
Therapies
Organizations Biomarkers Cancer types Therapies
EMA (1) CD33 + Acute Myeloid Leukemia Cytarabine, Daunorubicin, Gemtuzumab ozogamicin